5-BPDi
Appearance
From Wikipedia, the free encyclopedia
Chemical compound
![]() | |
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
UNII | |
Chemical and physical data | |
Formula | C19H27NO |
Molar mass | 285.431 g·mol−1 |
3D model (JSmol) | |
| |
|
5-BPDi (Indanyl-α-PHP) is a substituted cathinone derivative with stimulant effects which has been sold as a designer drug, first reported in 2015.[1][2]
See also
[edit]References
[edit]- ^ Błażewicz A, Bednarek E, Popławska M, Olech N, Sitkowski J, Kozerski L (July 2019). "Identification and structural characterization of synthetic cathinones: N-propylcathinone, 2,4-dimethylmethcathinone, 2,4-dimethylethcathinone, 2,4-dimethyl-α-pyrrolidinopropiophenone, 4-bromo-α-pyrrolidinopropiophenone, 1-(2,3-dihydro-1H-inden-5-yl)-2-(pyrrolidin-1-yl)hexan-1-one and 2,4-dimethylisocathinone". Forensic Toxicology. 37 (2): 288–307. doi:10.1007/s11419-018-00463-w.
- ^ Pulver B, Riedel J, Westphal F, Luhn S, Schönberger T, Schäper J, et al. (January 2023). "A new synthetic cathinone: 3,4-EtPV or 3,4-Pr-PipVP? An unsuccessful attempt to circumvent the German legislation on new psychoactive substances". Drug Testing and Analysis. 15 (1): 84–96. doi:10.1002/dta.3371. PMID 36136085.
Retrieved from "https://en.wikipedia.org/w/index.php?title=5-BPDi&oldid=1239880575"
Hidden categories: